Q3 EPS Estimates for Henry Schein Raised by Zacks Research

Henry Schein, Inc. (NASDAQ:HSIC) – Zacks Research boosted their Q3 2025 EPS estimates for shares of Henry Schein in a report released on Monday, May 26th. Zacks Research analyst R. Department now expects that the company will post earnings of $1.27 per share for the quarter, up from their prior forecast of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Zacks Research also issued estimates for Henry Schein’s Q3 2026 earnings at $1.35 EPS.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue was down .1% on a year-over-year basis. During the same period in the previous year, the business posted $1.10 EPS.

HSIC has been the subject of a number of other reports. Wells Fargo & Company reduced their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, February 26th. Wall Street Zen lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. Finally, Barrington Research reduced their price target on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a research note on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Trading Down 2.9%

Henry Schein stock opened at $69.86 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The firm has a 50-day moving average price of $67.65 and a two-hundred day moving average price of $71.63. The firm has a market capitalization of $8.50 billion, a price-to-earnings ratio of 28.75, a PEG ratio of 2.13 and a beta of 0.87. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Investment Management Corp VA ADV acquired a new stake in Henry Schein during the fourth quarter valued at approximately $32,000. Rakuten Securities Inc. acquired a new stake in shares of Henry Schein during the first quarter valued at approximately $34,000. Venturi Wealth Management LLC raised its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC raised its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC raised its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.